Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/28/2008US20080206221 Nicotinamide Riboside Kinase Compositions and Methods for Using the Same
08/28/2008US20080206220 Using NADH:flavin oxidoreductase as screening tool in identifying modulators for use in treatment of fungal infection
08/28/2008US20080206219 Using cytokine modulators as therapeutic tools in treatment of vascular permeability disorders
08/28/2008US20080206218 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy
08/28/2008US20080206217 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules
08/28/2008US20080206216 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy
08/28/2008US20080206209 Myelinating or remyelinating dysmyelinated or demyelinated axons comprising: administering oligondendrocyte progenitor cells to dysmyelinated or demyelinated axons via intraventricular, intracallosal or intraparenchymal administration to brain, brain stem or spinal cord
08/28/2008US20080206203 Administering leukotriene antagonist such as pranlukast
08/28/2008US20080206198 Using epithelial sodium channel (ENaC) inhibitor to treat and prevent nervous system and lung disorders
08/28/2008US20080206195 Compositions and Methods for Treating Disorders Associated with Abnormal Phosphate Metabolism
08/28/2008US20080206194 Inducing estrogen receptor-alpha expression by administering peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonist
08/28/2008US20080206193 Angiogenesis inhibitors; immunomodulators; side effect reduction
08/28/2008US20080206191 Compounds for the Treatment of Hepatitis C
08/28/2008US20080206188 polyethylene glycol monomethyl ether or dimethyl ether, polyoxypropylene glycol; for an inflamed epithelium at risk of developing gut-derived sepsis from an intestinal pathogen; labeled package
08/28/2008US20080206187 thermal ablation; polyethylene oxide-polypropylene oxide copolymer sensitizes neoplastic cells to hyperthermia
08/28/2008US20080206186 Tissues; 20 mol% acidic monmers: acrylic acid, monoacryloxyethyl phosphate, propene-1-sulfonic acid, vinyl benzoic acid, crotonic acid, itaconic acid, vinylsulfonic acid, vinyl acetic acid, citric acid, styrene sulfonic acid, sodium styrene sulfonate; porosity of at least 40%; interconnected pores
08/28/2008US20080206184 water soluble polymer conjugated to a drug; polymer is eliminated from the body without unwanted accumulation, as measured by formation of kidney vacuoles; PEG block polymers linked by labile hydrolytically or proteolytically degraded groups (amides); leptin, tumor necrosis factor receptor, L1-7 peptide
08/28/2008US20080206183 grafted with haptens or antigens, or an antibacterial or antifungal; hydrophobic polypeptides in the form of precipitates by polymerization of activated a-amino acid monomers in an aqueous solvent; polypeptide being capable of being resolubilized in said solvent; a-amino acid N-carboxyanhydride monomers
08/28/2008US20080206170 Creatine compositions for skin treatment
08/28/2008US20080206169 for skin lightening; preventing, retarding, and/or treating uneven skin tone; regulating the condition of mammalian keratinous tissue
08/28/2008US20080206163 INHIBITORS OF PHOSPHODIESTERASE (PDE) ISOENZYMES; USEFUL FOR TREATMENT OF RESPIRATORY DISORDERS SUCH AS ASTHMA; chronic obstructive pulmonary disease (COPD); 9,10-Dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one
08/28/2008US20080206162 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses
08/28/2008US20080206159 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions
08/28/2008US20080206158 1-(4-methoxyphenyl)-vinyl 4-tert-butylbenzoate; cosmetic, pharmaceutical, personal care and industrial preparations as sunscreens; ultraviolet radiation protection
08/28/2008US20080206156 Continuous spray scalp therapy and dispensing systems for same
08/28/2008US20080206154 Kill, inhibit growth or prevent the production of endogenously expressed toxin; treatment of sepsis
08/28/2008US20080206137 11C-Labeled Benzyl-Lactam Compounds and Their Use as Imaging Agents
08/28/2008US20080206136 Binding Peptidomimetics and Uses of the Same
08/28/2008US20080206135 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
08/28/2008US20080206130 In vivo panning for ligands to radiation-induced molecules
08/28/2008US20080202967 Treatment pad comprising hydrophilic polymer consisting of polyvinyl alcohol, polyoxyethylene glycol, polyacrylamide, polyacrylic acid, polyhydroxyethyl methacrylate, and/or polyoxyethylene glycol; preservatives and water; self-supporting; for eyes or surrounding tissue; containers conjoined by hinges
08/28/2008US20080202513 Use of Dry Powder Compositions For Pulmonary Delivery
08/28/2008DE112006002618T5 Verfahren und Zusammensetzungen zum selektiven Entfernen von Kaliumionen aus dem Gastrointestinaltrakt eines Säugers Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
08/28/2008DE112006002617T5 Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite Process for the preparation of core-shell composites or core-shell composites with networked cases and resulting core-shell composites
08/28/2008DE102007009494A1 New 1,6-naphthyridine or 8-azaquinazoline derivatives useful for treating aldosteronism, hypertension, cardiac insufficiency, myocardial infarct sequelae, liver cirrhosis, renal insufficiency and stroke
08/28/2008DE102007009401A1 Synergist effective during tauopathy comprises 1-aza-9-oxafluorene compound
08/28/2008DE102007009319A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
08/28/2008DE102007009264A1 New 9-alkyl-beta-carboline compounds are dopamine receptor stimulators useful to treat and/or prevent movement disorder, Alzheimer's disease, Parkinson's disease and Wilson's diseases, and as additives for accelerating cell growth
08/28/2008DE102007008840A1 Neue polymorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methylsulfonyl)phenyl]-3(2H)-pyridazinon (FHMP) Novel polymorph of 2- (4-fluorophenyl) -4-3-hydroxy-3-methyl-1-butoxy) -5- [4-methylsulfonyl) phenyl] -3 (2H) -pyridazinone (FHMP)
08/28/2008DE102007008839A1 Verfahren zur Herstellung von 4-(3-Hydroxy-3-methyl-butoxy)-5-[4-(methylsulfonyl)phenyl]-2-arylpyridazin-3(2H)-onen Process for the preparation of 4- (3-hydroxy-3-methyl-butoxy) -5- [4- (methylsulfonyl) phenyl] -2-arylpyridazin-3 (2H) -ones
08/28/2008DE102007008420A1 Benzimidazolderivate Benzimidazole derivatives
08/28/2008DE102007008419A1 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate 4- (pyrrolopyridinyl) -pyrimidinyl-2-amine derivatives
08/28/2008DE10164893B4 Verfahren zur Herstellung von Artischockenblätterextrakten und so erhaltene Artischockenblätterextrakte Process for the preparation of artichoke leaf extracts and extracts so obtained artichoke leaves
08/28/2008CA2689042A1 Compositions and methods for potentiated activity of biologicaly active molecules
08/28/2008CA2679921A1 Use of epimedium flavanoide and effective ingredient thereof for preparation of a medicament for promoting proliferation and differentiation of neural cells
08/28/2008CA2679602A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
08/28/2008CA2679310A1 Tetrasubstituted glucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
08/28/2008CA2679217A1 Use of riboflavin in the treatment of hypertension
08/28/2008CA2679173A1 Spirocyclic cyclohexane derivatives
08/28/2008CA2679166A1 Spirocyclic cyclohexane derivatives
08/28/2008CA2679066A1 Hydroxylamine compounds and methods of their use
08/28/2008CA2679028A1 Pharmaceutical formulation
08/28/2008CA2679016A1 Solid pharmaceutical and vaccine dose
08/28/2008CA2679010A1 Pellets comprising an active substance matrix resistant to gastric juice
08/28/2008CA2678975A1 Novel methods
08/28/2008CA2678958A1 Heterocyclic aspartyl protease inhibitors
08/28/2008CA2678907A1 Modulators of pharmacokinetic properties of therapeutics
08/28/2008CA2678846A1 Peroxisome proliferator activated receptor modulators
08/28/2008CA2678757A1 Ameliorating agent for insulin resistance
08/28/2008CA2678702A1 Process for the preparation of esomeprazole magnesium dihydrate
08/28/2008CA2678691A1 4-(pyrrolopyridinyl)pyrimidin-2-ylamine derivatives
08/28/2008CA2678687A1 Benzimidazole derivatives
08/28/2008CA2678677A1 Delta 9 - tetrahydrocannabinol processing
08/28/2008CA2678615A1 Substituted fused-ring compounds for inflammation and immune-related uses
08/28/2008CA2678514A1 Chemical linkers with single amino acids and conjugates thereof
08/28/2008CA2678200A1 Methods for modulating bone formation and mineralization
08/28/2008CA2678147A1 Indole derivatives
08/28/2008CA2678146A1 Compounds of formula (i) as serine protease inhibitors
08/28/2008CA2678088A1 Combination therapy using tnf and alfa-galactosyl ceramide
08/28/2008CA2677854A1 Composition for treating xerostomia or dry mouth
08/28/2008CA2677843A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/28/2008CA2677727A1 Pellets comprising an active substance matrix and a polymer coating, and a method for producing said pellets
08/28/2008CA2677706A1 Compounds and methods for modulating g protein-coupled receptors
08/28/2008CA2677705A1 Thiazole derivatives as modulators of g protein-coupled receptors
08/28/2008CA2677582A1 Pharmaceutical composition for prevention or treatment of disease associated with tear reduction
08/28/2008CA2677573A1 Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
08/28/2008CA2677565A1 Aryl carboxylic acid cyclohexyl amide derivatives
08/28/2008CA2676786A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
08/28/2008CA2676173A1 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/28/2008CA2675884A1 Quinoxaline compounds and use thereof
08/28/2008CA2675669A1 Novel compounds
08/28/2008CA2674300A1 Process for the production of high-purity 4a,5,9,10,11,12,-hexahydro-6h-benzofuro[3a,3,2-ef] [2] benzazepine and derivatives thereof
08/28/2008CA2672716A1 Novel therapeutic use for treating leukaemia
08/28/2008CA2652074A1 Substituted carboxamides as group 1 metabotropic receptor antagonists
08/28/2008CA2623560A1 A process for preparing stable amorphous benzimidazole composition
08/28/2008CA2622736A1 Drug containing adhesive preparation
08/27/2008EP1961823A1 Fermentation and culture method, fermented plant extract, composition containing fermented plant extract, method for producing lipopolysaccharide and lipopolysaccharide
08/27/2008EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer
08/27/2008EP1961771A1 Bismuth hyaluronate, the preparation method and the use theirof
08/27/2008EP1961757A1 Phosphoindoles as HIV inhibitors
08/27/2008EP1961756A1 Novel bisboron compound
08/27/2008EP1961754A1 Bicyclic heterocyclic compound
08/27/2008EP1961753A1 Pyrazolopyrimidinone derivatives, their preparation and their use
08/27/2008EP1961752A2 Piperidine Compounds
08/27/2008EP1961751A1 Acid addition salt of optically active dihydropyridine derivative
08/27/2008EP1961750A1 Vla-4 inhibitory drug
08/27/2008EP1961749A1 Acid addition salt of dihydropyridine derivative
08/27/2008EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
08/27/2008EP1961747A2 Borrelidin-producing polyketide synthase and its uses
08/27/2008EP1961745A1 Bicyclic heterocyclic compound
1 ... 3114 3115 3116 3117 3118 3119 3120 3121 3122 3123 3124 3125 3126 3127 3128 3129 3130 3131 3132 3133 3134 ... 7860